N/A
N=85
New Technologies to Help Manage ADHD
Attention Deficit Hyperactivity Disorder
Bottom Line
View on ClinicalTrials.gov: NCT02390791 ↗Enrolled (actual)
85
Serious AEs
0.0%
Results posted
Sep 2019
Primary outcome: Primary: Medication Continuity: The Number of Days Covered With Medicine — 108.8; 133.3 Days — p=0.04
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- enhanced myADHDportal.com (Other); treatment as usual standard portal (Other)
- Age
- Pediatric · 6+ yrs
- Sex
- All
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Primary completion
- Aug 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Medication Continuity: The Number of Days Covered With Medicine |
108.8; 133.3 | 0.04 sig |
| SECONDARY Parent-reported Necessity to Concerns Differential (Beliefs About Medication Scale) |
0.44; -0.06 | 0.89 |
| SECONDARY Parent-reported Decisional Conflict (Decisional Conflict Scale) |
14.06; 20.31 | 0.85 |
| SECONDARY Parent Trust in Provider (Trust in Provider Scale) |
45.0; 41.5 | 0.69 |
| SECONDARY Working Alliance Inventory |
50.0; 46.0 | 0.13 |
| SECONDARY Parent Perceived Social Support (Perceived Social Support Scale) |
54.00; 68.95 | 0.94 |
| SECONDARY Parent Distress (Parenting Stress Index - Short Form) |
75.57; 74.00 | 0.88 |
| SECONDARY Number of Participants With Side Effects Rated by Parents as Moderate or Severe on the Pittsburgh Side Effects Rating Scale |
13; 9 | 0.15 |
| SECONDARY Total Number of myADHDportal.Com Log-ins by Parent |
11.33; 8.47 | 0.48 |
| SECONDARY Total Number of Measures Completed by Parents to Track Child Response to Treatment |
2.50; 2.31 | 0.71 |
Summary
Cluster randomized controlled trial to evaluate the general effectiveness of intervention compared to control on medication continuity as measured by prescriptions written and other more proximal outcomes during the first six months of treatment.
Eligibility Criteria
Inclusion Criteria
- Parents of children are eligible to participate if
- their child receives ADHD care at one of the pediatric primary care practices that is partnering to conduct this trial
- child being registered on myADHDportal.com to initiate child assessment of ADHD
- child age 6-10 years
- child must not have been previously treated with ADHD medication
- child prescribed ADHD medication within 12 months of enrolling in the study
Exclusion Criteria
- Unable to read and speak English
Data sourced from ClinicalTrials.gov (NCT02390791). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.